Effects of Chinese traditional compound, JinSanE, on expression of TGF-&beta;1 and TGF-&beta;1 type II receptor mRNA, Smad3 and Smad7 on experimental hepatic fibrosis in vivo

doi:10.3748/wjg.v11.i15.2269

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 15

This Article

Reference Citation Analysis (0)

(0)

(5497)

(11)

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Basic Research

World J Gastroenterol. Apr 21, 2005; 11(15): 2269-2276
Published online Apr 21, 2005. doi: 10.3748/wjg.v11.i15.2269

Full Size Figure Download Figure

Figure 3 Immunohistochemical staining for TGF-β1 in liver sections. ×400 for A, B, C and D. (A) TGF-β1 immunoreactivity was evenly distributed within the interstitial tissue and liver sinusoidal in the normal group; (B) Stout connective tissue septa were strongly immunoreactive for TGF-β1 in the model group; (C) The staining intensity was much weaker in JinSanE group I than that in the model group; and (D) The staining positivity in JinSanE group II was stronger than that in the JinSanE group II, but still less than that in the model group.

Citation: Song SL, Gong ZJ, Zhang QR, Huang TX. Effects of Chinese traditional compound, JinSanE, on expression of TGF-β1 and TGF-β1 type II receptor mRNA, Smad3 and Smad7 on experimental hepatic fibrosis in vivo. World J Gastroenterol 2005; 11(15): 2269-2276
URL: https://www.wjgnet.com/1007-9327/full/v11/i15/2269.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i15.2269

Song SL, Gong ZJ, Zhang QR, Huang TX. Effects of Chinese traditional compound, JinSanE, on expression of TGF-β1 and TGF-β1 type II receptor mRNA, Smad3 and Smad7 on experimental hepatic fibrosis in vivo. World J Gastroenterol 2005; 11(15): 2269-2276 [PMID: 15818738 DOI: 10.3748/wjg.v11.i15.2269]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.